Sponsor Pipeline

Beijing GoBroad Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
18
Active Trials
14
Recruiting
10
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-26 NCT07605637 Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of… Not Yet Recruiting
2026-05-18 NCT07593911 A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune… Not Yet Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
5
Phase 1
4
Early Phase 1
2
Not specified
6
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07520357 A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of… Advanced Neuroendocrine Carcinoma Not Yet Recruiting
Phase 1/2
NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH Refractory Lupus Nephritis Recruiting
NCT06947473 Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. Refractory Lupus Nephritis Recruiting
NCT06316856 CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory… T-Cell Acute Lymphocytic Leukemia Recruiting
NCT06585514 Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE) Recruiting
NCT06688799 Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases Autoimmune Diseases Recruiting
Phase 1
NCT07329894 Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen… Gastrointestinal Cancer Recruiting
NCT06326008 Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged… B-cell Acute Lymphoblastic Leukemia Recruiting
NCT06822881 CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus… Systemic Lupus Erythematosus (SLE) Recruiting
NCT06326021 Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia Refractory/Relapsed Acute Myeloid Leukaemia Recruiting
Early Phase 1
NCT07242417 TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors Solid Cancer Recruiting
NCT06890494 Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell… Leukemia Recruiting
Not specified
NCT06389305 CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic… B-cell Acute Lymphoblastic Leukemia Recruiting
NCT07143617 Exploratory Clinical Study on the Safety of STR-P004 Autoimmune Diseases Recruiting
NCT06343090 Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to… B-cell Acute Lymphoblastic Leukemia Recruiting
NCT07538856 Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric… Gastric Not Yet Recruiting
NCT07593911 A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune… Systemic Lupus Erthematosus (SLE) Not Yet Recruiting
NCT07605637 Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of… Relapsed/Refractory Autoimmune Diseases Not Yet Recruiting
Disease Areas
Get alerts when Beijing GoBroad Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free